EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HSP90 inhibition partially rescues alternative splicing dysregulation in cell models of myotonic dystrophy

Jing Zhang, Amy Mascorro, Humayra Oishi, Asmar Aliyeva, Sharon Shaughnessy, Jia Sheng, Kaalak Reddy, John Douglas Cleary, J Andrew Berglund

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.113354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Jing Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: RNA Institute, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA; Department of Biological Sciences, College of Arts an…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Myotonic Dystrophy, Alternative Splicing. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, US Department of War.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are multisystemic diseases caused by the expression of toxic expansion RNAs that sequester muscleblind-like (MBNL) proteins, resulting in extensive alternative splicing dysregulation. Given that there are no current disease-modifying treatments for DM, we sought to identify compounds that rescue the underlying splicing dysregulation. A medium throughput splicing screen utilizing DM1 patient-derived fibroblasts was developed and used to screen 1584 compounds from the NIH NCI Diversity Set VI, leading to the identification of macbecin II, an HSP90 inhibitor. Macbecin II-mediated HSP90 inhibition corrects several MBNL-regulated splicing events in DM1 myotubes, and a structurally distinct HSP90 inhibitor, CCT018159, produces similar effects. Using RT-PCR splicing analysis, siRNA knockdown, RT-qPCR, immunoblotting, and RNA fluorescence in situ hybridization we examined the effects of HSP90 inhibition in DM models. HSP90 inhibition increases MBNL1 and MBNL2 transcript levels, increases MBNL2 protein, and reduces toxic CUG RNA and nuclear foci in DM1 cell models. An analysis of individual HSP90 isoforms reveals that knocking down HSP90AA1, HSP90AB1, and TRAP1 partially improves splicing defects, whereas HSP90B1 knockdown exacerbates mis-splicing. We also show that treatment with HSP90 inhibitors corrects mis-splicing in DM2 myotubes. Together, these data identify HSP90 as a modifier of RNA toxicity and alternative splicing in DM and support further evaluation of HSP90-directed therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HSP90 Heat-Shock ProteinsMyotonic DystrophyAlternative SplicingHumansRNA-Binding Proteins

Stichwörter der Autor:innen

HSP90MBNLRNA focialternative splicingmyotonic dystrophysmall-molecule screening

Substanzen

HSP90 Heat-Shock ProteinsRNA-Binding ProteinsMBNL1 protein, human

Autor:innen und Institutionen

  • RNA Institute, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA; Department of Biological Sciences, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA.
  • RNA Institute, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA; Department of Chemistry, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA.
  • RNA Institute, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA.
  • RNA Institute, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA; Department of Biological Sciences, College of Arts and Sciences, University at Albany, SUNY, Albany, New York, USA. Electro…

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • US Department of War
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute of Neurological Disorders and Stroke
  • National Institute of General Medical Sciences
  • National Institutes of Health

Zitieren

APA

Zhang, J., Mascorro, A., Oishi, H., Aliyeva, A., Shaughnessy, S., Sheng, J., Reddy, K., Cleary, J. D., & Berglund, J. A. (2026). HSP90 inhibition partially rescues alternative splicing dysregulation in cell models of myotonic dystrophy. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.113354

Vancouver

Zhang J, Mascorro A, Oishi H, Aliyeva A, Shaughnessy S, Sheng J, et al. HSP90 inhibition partially rescues alternative splicing dysregulation in cell models of myotonic dystrophy. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.113354

BibTeX
@article{Zhang2026,
  author = {Zhang, Jing and Mascorro, Amy and Oishi, Humayra and Aliyeva, Asmar and Shaughnessy, Sharon and Sheng, Jia and Reddy, Kaalak and Cleary, John Douglas and Berglund, J Andrew},
  title = {HSP90 inhibition partially rescues alternative splicing dysregulation in cell models of myotonic dystrophy},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.113354}
}
Kostenlos starten →